Related Experiment Video
Updated: May 25, 2026

Measuring Global Cellular Matrix Metalloproteinase and Metabolic Activity in 3D Hydrogels
Published on: January 22, 2019
The proteolytic activity of MT4-MMP is required for its pro-angiogenic and pro-metastatic promoting effects
Lorin Host1, Alexandra Paye, Benoit Detry
1Laboratory of Tumor and Developmental Biology, Groupe Interdisciplinaire de Génoprotéomique Appliquée-Cancer, GIGA-Cancer, University of Liege, Liège, Belgium.
Abstract:
Membrane-type 4 matrix metalloprotease (MT4-MMP) expression in breast adenocarcinoma stimulates tumor growth and metastatic spreading to the lung. However, whether these pro-tumorigenic and pro-metastatic effects of MT4-MMP are related to a proteolytic action is not yet known. Through site directed mutagenesis MT4-MMP has been inactivated in cancer cells through Glutamic acid 249 substitution by Alanine in the active site. Active MT4-MMP triggered an angiogenic switch at day 7 after tumor implantation and drastically accelerated subcutaneous tumor growth as well as lung colonization in recombination activating gene-1-deficient mice. All these effects were abrogated upon MT4-MMP inactivation. In sharp contrast to most MMPs being primarily of stromal origin, we provide evidence that tumor-derived MT4-MMP, but not host-derived MT4-MMP contributes to angiogenesis. A genetic approach using MT4-MMP-deficient mice revealed that the status of MT4-MMP produced by host cells did not affect the angiogenic response. Despite of this tumor intrinsic feature, to exert its tumor promoting effect, MT4-MMP requires a permissive microenvironment. Indeed, tumor-derived MT4-MMP failed to circumvent the lack of an host angio-promoting factor such as plasminogen activator inhibitor-1. Overall, our study demonstrates the key contribution of MT4-MMP catalytic activity in the tumor compartment, at the interface with host cells. It identifies MT4-MMP as a key intrinsic tumor cell determinant that contributes to the elaboration of a permissive microenvironment for metastatic dissemination.
Insights
The catalytic activity of membrane-type 4 matrix metalloprotease (MT4-MMP) drives breast cancer growth and metastasis. Inactivating MT4-MMP
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Membrane-type 4 matrix metalloprotease (MT4-MMP) is linked to breast adenocarcinoma progression and metastasis.
- The precise mechanism, particularly the role of MT4-MMP's proteolytic activity, in promoting tumor growth and spread remains unclear.
Purpose of the Study:
- To investigate whether the pro-tumorigenic and pro-metastatic effects of MT4-MMP are dependent on its catalytic activity.
- To elucidate the contribution of tumor-derived versus host-derived MT4-MMP in angiogenesis and tumor promotion.
Main Methods:
- Site-directed mutagenesis was employed to inactivate MT4-MMP by substituting Glutamic acid 249 with Alanine in the active site.
- Tumor growth, lung metastasis, and angiogenesis were assessed in vivo using genetically modified mice (recombination activating gene-1-deficient and MT4-MMP-deficient).
- The requirement for a permissive microenvironment, including host angio-promoting factors like plasminogen activator inhibitor-1, was evaluated.
Main Results:
- Active MT4-MMP significantly accelerated tumor growth and lung metastasis, alongside triggering an angiogenic switch.
- These pro-tumorigenic effects were completely abolished upon MT4-MMP inactivation, highlighting the importance of its catalytic activity.
- Tumor-derived MT4-MMP, not host-derived MT4-MMP, was found to contribute to angiogenesis, though it required host factors like PAI-1 to promote tumors.
Conclusions:
- The catalytic activity of MT4-MMP within the tumor compartment is crucial for stimulating tumor growth and metastasis.
- MT4-MMP acts as an intrinsic tumor cell determinant that shapes a permissive microenvironment conducive to cancer dissemination.
- Targeting MT4-MMP's proteolytic function represents a potential therapeutic strategy for breast cancer.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
PI3K/mTOR/AKT Signaling Pathway
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply
Microtubule Associated Proteins (MAPs)
